ES2191781T3 - Comprimido de liberacion rapida que comprende acido tolfenamico o una sal farmaceuticamente aceptable del mismo. - Google Patents

Comprimido de liberacion rapida que comprende acido tolfenamico o una sal farmaceuticamente aceptable del mismo.

Info

Publication number
ES2191781T3
ES2191781T3 ES96943021T ES96943021T ES2191781T3 ES 2191781 T3 ES2191781 T3 ES 2191781T3 ES 96943021 T ES96943021 T ES 96943021T ES 96943021 T ES96943021 T ES 96943021T ES 2191781 T3 ES2191781 T3 ES 2191781T3
Authority
ES
Spain
Prior art keywords
pharmaceutically acceptable
same
acceptable salt
quick release
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96943021T
Other languages
English (en)
Inventor
Knud Erik Gebhard-Hansen
Karen Bjornsdottir
Lars Hedevang Christensen
Soren Bols Pedersen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hexal AS
Original Assignee
GEA Farmaceutisk Fabrik AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GEA Farmaceutisk Fabrik AS filed Critical GEA Farmaceutisk Fabrik AS
Application granted granted Critical
Publication of ES2191781T3 publication Critical patent/ES2191781T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE DESCRIBE UN COMPRIMIDO DE LIBERACION RAPIDA QUE INCLUYE UN PRINCIPIO ACTIVO SELECCIONADO ENTRE EL ACIDO TOLFENAMICO Y LAS SALES FARMACEUTICAMENTE ACEPTABLES DEL MISMO. EL PRINCIPIO ACTIVO PRESENTA UN TAMAÑO DE PARTICULA MEDIO DE 10 MI M. EL COMPRIMIDO INCLUYE ACIDO ALGINICO O UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO, EN UNA CANTIDAD DESDE UN 1,5 - 6,0 % EN PESO, Y UN SUPERDISGREGANTE EN UNA CANTIDAD DE AL MENOS UN 6 % EN PESO.
ES96943021T 1995-12-20 1996-12-19 Comprimido de liberacion rapida que comprende acido tolfenamico o una sal farmaceuticamente aceptable del mismo. Expired - Lifetime ES2191781T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK144895 1995-12-20

Publications (1)

Publication Number Publication Date
ES2191781T3 true ES2191781T3 (es) 2003-09-16

Family

ID=8104933

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96943021T Expired - Lifetime ES2191781T3 (es) 1995-12-20 1996-12-19 Comprimido de liberacion rapida que comprende acido tolfenamico o una sal farmaceuticamente aceptable del mismo.

Country Status (27)

Country Link
US (1) US6036975A (es)
EP (1) EP0869783B1 (es)
JP (1) JP2000515489A (es)
CN (1) CN1147295C (es)
AR (1) AR004395A1 (es)
AT (1) ATE234085T1 (es)
AU (1) AU1190097A (es)
BR (1) BR9612057A (es)
CA (1) CA2244396A1 (es)
CZ (1) CZ293422B6 (es)
DE (1) DE69626676T2 (es)
DK (1) DK0869783T3 (es)
EE (1) EE9800186A (es)
ES (1) ES2191781T3 (es)
HR (1) HRP960598A2 (es)
HU (1) HU224030B1 (es)
IL (1) IL124356A (es)
MX (1) MX9803918A (es)
NO (1) NO316869B1 (es)
NZ (1) NZ324674A (es)
PL (1) PL186915B1 (es)
RO (1) RO117589B1 (es)
RU (1) RU2166939C2 (es)
TR (1) TR199801126T2 (es)
TW (1) TW430561B (es)
WO (1) WO1997022340A1 (es)
ZA (1) ZA9610714B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802973D0 (sv) 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6599530B2 (en) * 1998-09-14 2003-07-29 Orion Corporation Oral compacted composition comprising catechol derivatives
IL150053A0 (en) * 1999-12-06 2002-12-01 Mendell Co Inc Edward Pharmaceutical superdisintegrant
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
US20050084914A1 (en) * 2003-09-15 2005-04-21 Foulkes J. G. Assays with primary cells
EP1998763A4 (en) * 2006-03-24 2010-03-03 Texas A & M Univ System And Sa USES OF DIPHENYLCARBOXYLIC ACIDS AND CARBOXYLIC ACIDS WITH DIPHENYLAMINE FUNCTION
TWI405574B (zh) * 2007-06-21 2013-08-21 Otsuka Pharma Co Ltd 藥學固體製劑及其製造方法
US8367427B2 (en) * 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
US11389454B2 (en) * 2016-09-07 2022-07-19 Celgene Corporation Tablet compositions
CN111184707B (zh) * 2020-02-20 2021-04-27 中山大学 托芬那酸或其药学上可接受的盐在制备预防和/或治疗新型冠状病毒炎症药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE116061C (es) *
FI89004C (fi) * 1988-02-16 1993-08-10 Pertti J Neuvonen Anvaendning av tillsatsmedel foer oekning av absorptionshastigheten av laekemedel i orala laekemedelspreparat
IT1276689B1 (it) * 1995-06-09 1997-11-03 Applied Pharma Res Forma farmaceutica solida ad uso orale

Also Published As

Publication number Publication date
HUP9903410A2 (hu) 2000-04-28
NZ324674A (en) 2000-01-28
CZ194398A3 (cs) 1998-11-11
PL186915B1 (pl) 2004-03-31
EP0869783B1 (en) 2003-03-12
RU2166939C2 (ru) 2001-05-20
HUP9903410A3 (en) 2000-05-29
ATE234085T1 (de) 2003-03-15
CN1208345A (zh) 1999-02-17
HRP960598A2 (en) 1998-02-28
NO982875L (no) 1998-08-19
DK0869783T3 (da) 2003-06-02
DE69626676T2 (de) 2003-12-18
TR199801126T2 (xx) 1998-08-21
IL124356A (en) 2001-05-20
DE69626676D1 (de) 2003-04-17
IL124356A0 (en) 1998-12-06
CN1147295C (zh) 2004-04-28
TW430561B (en) 2001-04-21
WO1997022340A1 (en) 1997-06-26
AR004395A1 (es) 1998-11-04
CZ293422B6 (cs) 2004-04-14
AU1190097A (en) 1997-07-14
US6036975A (en) 2000-03-14
RO117589B1 (ro) 2002-05-30
EP0869783A1 (en) 1998-10-14
NO316869B1 (no) 2004-06-07
BR9612057A (pt) 1999-02-23
JP2000515489A (ja) 2000-11-21
NO982875D0 (no) 1998-06-19
HU224030B1 (hu) 2005-05-30
ZA9610714B (en) 1997-06-30
EE9800186A (et) 1998-12-15
PL327584A1 (en) 1998-12-21
CA2244396A1 (en) 1997-06-26
MX9803918A (es) 1998-09-30

Similar Documents

Publication Publication Date Title
PE20001322A1 (es) Composicion multiparticula de liberacion modificada
DE69940557D1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
ES2191781T3 (es) Comprimido de liberacion rapida que comprende acido tolfenamico o una sal farmaceuticamente aceptable del mismo.
HK1010722A1 (en) Benzoyl guanidines, their production and their use in medicaments
AR084101A2 (es) Comprimido de carga de droga alta y proceso para su preparacion
DK0717617T3 (da) Mikropartikler indeholdende aktive bestanddele og gas
IT8719064A0 (it) Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive.
ES2191682T3 (es) Nueva formulacion farmaceutica.
ES2060825T3 (es) Un sistema terapeutico para el administracion retardada y controlada de sustancias activas por via percutanea o a traves de la mucosa.
CA2087435A1 (en) Use of interfacially-polymerized membranes in delivery devices
NO20016108D0 (no) Kontrollert frigivelse og smaks maskerende orale farmasöytiske sammensetninger
GEP20022752B (en) Valaciclovir Tablets Containing Colloidal Silicon Dioxide
CO5160287A1 (es) Formulacion de liberacion controlada de divalproex sodico
AR026968A1 (es) Una tableta matriz que permite la liberacion prolongada de trimetazidina lluego de su administracion por via oral
ATE541028T1 (de) Verpackungssystem für wasch- oder reinigungsmittel
ES2118108T3 (es) Productos de limpieza liquidos.
DE69102704T2 (de) Orales, melatonin enthaltendes arzneimittel.
YU72194A (sh) Injekcione suspenzije sa produženim dejstvom i postupak za proizvodnju istih
AR012946A1 (es) Forma cristalina a de 1-(2,6-difluorbencil)-1h-1,2,3-triazol-4-carboxamida, preparaciones farmaceuticas que los contienen y su uso para la preparacion de medicamentos
FI963567A (fi) Diklofenakki-Na:a sisältävä depottabletti
ES2191908T3 (es) 4-aminopirrol(3,2-d)pirimidinas como antagonistas del receptor del neuropeptido.
DE69841260D1 (de) Bakterielle pheromone und deren verwendungen
AR248350A1 (es) Metodo para preparar una tableta de aminoguanidina de compresion directa.
IT1263222B (it) Composizione farmaceutica per la somministrazione attraverso le mucose.
DE69323191T2 (de) Wasserlösliche retinoide